These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11487673)

  • 21. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
    Kudo T; Chandra FA; Ahn SS
    J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
    Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
    Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Femoropopliteal artery stent placement: evaluation of long-term success.
    Strecker EP; Boos IB; Göttmann D
    Radiology; 1997 Nov; 205(2):375-83. PubMed ID: 9356617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Femoropopliteal bypass vs percutaneous transluminal angioplasty and stenting in treatment of peripheral artery diseases of infrainquinal segment - short-term results.
    Cvetanovski MV; Jovev S; Cvetanovska M; Blazevski B; Colanceski R; Andreevska T; Gramatnikovski N; Kartalov A
    Prilozi; 2009 Jul; 30(1):105-18. PubMed ID: 19736534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous angioplasty and stenting of the superficial femoral artery.
    Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
    J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stenting of failing above-knee femoropopliteal percutaneous transluminal angioplasty].
    Pedersen G; Laxdal E; Wirsching J; Aune S
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2437-8. PubMed ID: 14562780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD study.
    Jahnke T; Mueller-Huelsbeck S; Charalambous N; Trentmann J; Jamili A; Huemme TH; Bolte H; Heller M; Schaefer PJ
    J Vasc Interv Radiol; 2010 Feb; 21(2):186-94. PubMed ID: 20123205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts.
    Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Schwarzinger I; Wagner O; Minar E
    J Endovasc Ther; 2003 Jun; 10(3):557-65. PubMed ID: 12932168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis.
    Pokrajac B; Pötter R; Maca T; Fellner C; Mittlböck M; Ahmadi R; Seitz W; Minar E
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):923-31. PubMed ID: 11072147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Clinical Outcomes of Percutaneous Transluminal Angioplasty with Optional Stenting in Patients with Superficial Femoral Artery Disease: A Retrospective, Observational Analysis.
    Vossen RJ; Vahl AC; Leijdekkers VJ; Montauban van Swijndregt AD; Balm R
    Eur J Vasc Endovasc Surg; 2018 Nov; 56(5):690-698. PubMed ID: 30108029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study.
    Minar E; Pokrajac B; Maca T; Ahmadi R; Fellner C; Mittlböck M; Seitz W; Wolfram R; Pötter R
    Circulation; 2000 Nov; 102(22):2694-9. PubMed ID: 11094034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4-year follow-up.
    Henry M; Amor M; Ethevenot G; Henry I; Amicabile C; Beron R; Mentre B; Allaoui M; Touchot N
    Radiology; 1995 Oct; 197(1):167-74. PubMed ID: 7568818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central venous occlusion in hemodialysis access: Comparison between percutaneous transluminal angioplasty alone and nitinol or stainless-steel stent placement.
    Gür S; Oğuzkurt L; Gedikoğlu M
    Diagn Interv Imaging; 2019 Sep; 100(9):485-492. PubMed ID: 30952526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
    Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial.
    Jahnke T; Andresen R; Müller-Hülsbeck S; Schäfer FK; Voshage G; Heller M; Brossmann J
    J Vasc Interv Radiol; 2003 Jan; 14(1):41-51. PubMed ID: 12525585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series.
    Conrad MF; Cambria RP; Stone DH; Brewster DC; Kwolek CJ; Watkins MT; Chung TK; LaMuraglia GM
    J Vasc Surg; 2006 Oct; 44(4):762-9. PubMed ID: 17012001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transluminal stenting for femoropopliteal occlusive disease: analysis of restenosis by serial arteriography.
    Bui TD; Gordon IL; Nguyen T; Fujitani RM; Wilson SE; Conroy RC
    Ann Vasc Surg; 2006 Mar; 20(2):200-8. PubMed ID: 16555031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.